Results 91 to 100 of about 11,403 (144)

Symptom heterogeneity and patient subgroup classification among US patients with post-treatment Lyme disease: an observational study. [PDF]

BMJ Open, 2021
Rebman AW, Yang T, Aucott JN.
europepmc   +1 more source

Investigation of Possible Link between Interferon-α and Lyme Disease

Emerging Infectious Diseases, 2023
Armin Alaedini, Mary K. Crow, Brian A. Fallon, Elzbieta Jacek, Gary P. Wormser   +4 more
doaj   +1 more source

Aberrant T-cell phenotypes in a cohort of patients with post-treatment Lyme disease. [PDF]

Front Immunol
Girgis AA, Cimbro R, Yang T, Rebman AW, Sewell T, Villegas de Flores D, Vadalia A, Robinson WH, Cox AL, Darrah E, Soloski MJ, Aucott J.   +11 more
europepmc   +1 more source

Autonomic Symptoms in Post-Treatment Lyme Disease: Insights From the COMPASS-31 and the 10-Minute Active Stand Test. [PDF]

Mayo Clin Proc Innov Qual Outcomes
Adler BL, Rebman AW, Chung T, Miller JB, Keshtkarjahromi M, Yang T, Savigamin C, Azola A, Rowe PC, Aucott JN.   +9 more
europepmc   +1 more source

Development of Low-Dose Disulfiram Rectal Suppository Intended for Application in Post-Treatment Lyme Disease Syndrome. [PDF]

Pharmaceutics
Benkő BM, Szabó BI, Kádár S, Szabó E, Tóth G, Szente L, Tonka-Nagy P, Zelkó R, Sebe I.   +8 more
europepmc   +1 more source

Prevalence of Rheumatoid Factor and Anti-citrullinated Protein Antibodies in Patients With Post-treatment Lyme Disease. [PDF]

Cureus
Miller JB, Rebman A, Yang T, Aucott J.
europepmc   +1 more source

Guidelines for Lyme borreliosis: post-treatment Lyme disease syndrome (PTLDS)

Infectious Diseases Now
P. Arias, X. Gocko, F. Roblot, Y. Hansmann, E. Baux, C. Eldin, S. Nguala, A. Gautier, C. Lemogne, A. Raffetin   +9 more
openaire   +1 more source

Anti-lysoganglioside and other anti-neuronal autoantibodies in post-treatment Lyme Disease and Erythema Migrans after repeat infection. [PDF]

Brain Behav Immun Health, 2020
Fallon BA, Strobino B, Reim S, Stoner J, Cunningham MW.   +4 more
europepmc   +1 more source

Estimation of cumulative number of post-treatment Lyme disease cases in the US, 2016 and 2020. [PDF]

BMC Public Health, 2019
DeLong A, Hsu M, Kotsoris H.
europepmc   +1 more source

Combining Double-Dose and High-Dose Pulsed Dapsone Combination Therapy for Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome and Co-Infections, Including Bartonella: A Report of 3 Cases and a Literature Review. [PDF]

Microorganisms
Horowitz RI, Fallon J, Freeman PR.
europepmc   +1 more source